Shanghai startup's gene therapy restores hearing in five deaf children, running ahead of Lilly and Regeneron trials
Five of six children who had been deaf since or soon after birth can now hear after receiving a gene therapy developed by Shanghai Refreshgene …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
